July 26, 2017 11:31 AM ET

Biotechnology

Company Overview of Agouron Pharmaceuticals, Inc.

Key Executives for Agouron Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Glenn R. Zinser No RelationshipsCorporate Vice President of Operations74
Marvin R. Brown M.D. 3 RelationshipsVice President and President of Alanex70

Agouron Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Irving S. Johnson Ph.D.No RelationshipsAgouron Pharmaceuticals, Inc.91
View All Board Members

Agouron Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.2K
Bonus
236.8K
Total Short Term Compensation
484.6K
Total Value of Options
18.3M
Compensation as of Fiscal Year
Agouron Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Kiadis Pharma N.V Appoints Otto Schwarz as Supervisory Board Member
July 26, 2017 5:00 AM ET
Abeona Therapeutics Inc. Names Juan Ruiz as Chief Medical Officer
July 25, 2017 12:05 PM ET
Nivalis Therapeutics, Inc. Announces Management Changes
July 25, 2017 11:06 AM ET
Intellia Therapeutics Inc. Announces Executive Changes
July 24, 2017 10:30 PM ET
PTC Therapeutics, Inc. Announces the Promotion of Joseph McIntosh to Senior Vice President and Head of Clinical Development
July 24, 2017 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Agouron Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.